1-7 of 7
Christopher D. Fegan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target

Emma Kennedy, Eve Coulter, Emma Halliwell, Nuria Profitos-Peleja, Elisabeth Walsby, Barnaby Clark, Elizabeth H. Phillips, Thomas A. Burley, Simon Mitchell, Stephen Devereux, Christopher D. Fegan, Christopher I. Jones, Rosalynd Johnston, Tim Chevassut, Ralph Schulz, Martina Seiffert, Angelo Agathanggelou, Ceri Oldreive, Nicholas Davies, Tatjana Stankovic, Triantafillos Liloglou, Chris Pepper, Andrea G. S. Pepper
Journal: Blood
Blood (2021) 137 (22): 3064–3078.
https://doi.org/10.1182/blood.2020005964
Published: 2021
Includes: Supplemental data
Journal Articles

Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses

Clinical Trials & Observations
Donald W. Milligan, Savio Fernandes, Ranjit Dasgupta, Faith E. Davies, Estella Matutes, Christopher D. Fegan, Christopher McConkey, J. Anthony Child, David Cunningham, Gareth J. Morgan, Daniel Catovsky, for the National Cancer Research Institute (NCRI) Haematological Studies Group
Journal: Blood
Blood (2005) 105 (1): 397–404.
https://doi.org/10.1182/blood-2004-01-0298
Published: 2005
Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD
Journal: Blood
Blood (2004) 104 (11): 3286.
https://doi.org/10.1182/blood.V104.11.3286.3286
Published: 2004
Journal Articles

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Mark A. Cook, Donald W. Milligan, Christopher D. Fegan, Philip J. Darbyshire, Premini Mahendra, Charles F. Craddock, Paul A. H. Moss, David C. Briggs
Journal: Blood
Blood (2004) 103 (4): 1521–1526.
https://doi.org/10.1182/blood-2003-02-0438
Published: 2004
Journal Articles

Reconstitution of the Epstein-Barr virus–specific cytotoxic T-lymphocyte response following T-cell–depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

Clinical Trials & Observations Brief Report
Suparno Chakrabarti, Donald W. Milligan, Deenan Pillay, Stephen Mackinnon, Kathleen Holder, Narinder Kaur, Dorothy McDonald, Christopher D. Fegan, Herman Waldmann, Geoff Hale, Alan Rickinson, Neil Steven
Journal: Blood
Blood (2003) 102 (3): 839–842.
https://doi.org/10.1182/blood.V102.3.839
Published: 2003
Journal Articles

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

Clinical Trials & Observations
Suparno Chakrabarti, Stephen Mackinnon, Raj Chopra, Panagiotis D. Kottaridis, Karl Peggs, Peter O'Gorman, Ronjon Chakraverty, Timothy Marshall, Husam Osman, Premini Mahendra, Charles Craddock, Herman Waldmann, Geoff Hale, Christopher D. Fegan, Kwee Yong, Anthony H. Goldstone, David C. Linch, Donald W. Milligan
Journal: Blood
Blood (2002) 99 (12): 4357–4363.
https://doi.org/10.1182/blood.V99.12.4357
Published: 2002
Journal Articles

Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Rebecca L. Auer, Christopher Jones, Roman A. Mullenbach, Denise Syndercombe-Court, Donald W. Milligan, Christopher D. Fegan, Finbarr E. Cotter
Journal: Blood
Blood (2001) 97 (2): 509–515.
https://doi.org/10.1182/blood.V97.2.509
Published: 2001